BLANVER FARMOQUIMICA E FARMACEUTICA S.A: public contracts won without a rival in Brazil

Updated 17 October 2026 · 2024-02-06 to 2026-06-10 · all of Brazil · record in the register

BLANVER FARMOQUIMICA E FARMACEUTICA S.A: public contracts won without a rival in Brazil: 10 uncontested awards; 62% of its awards; 10 without a competition; 0 single bid.

Assay record ASY-BR-0I0SUUQ03G · Cite as: Assay Systems, “BLANVER FARMOQUIMICA E FARMACEUTICA S.A: public contracts won without a rival in Brazil”, https://assay-systems.com/register/br/uncontested/s/blanver-farmoquimica-e-farmaceutica-s-a/

1
10uncontested awards
62%of its awards
10without a competition
0single bid

BLANVER FARMOQUIMICA E FARMACEUTICA S.A won 10 of its 16 public contract awards in Brazil without a rival from 2024-02-06 to 2026-06-10: 10 without a competition and 0 after a competition that drew a single bid. 2 buyers awarded it without a rival, the largest FUNDACAO OSWALDO CRUZ with 8.

An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.

Buyers that awarded it without a rival

FUNDACAO OSWALDO CRUZ8uncontested8awards100%of these awards

FUNDACAO OSWALDO CRUZ gave BLANVER FARMOQUIMICA E FARMACEUTICA S.A 8 awards: 8 without a competition, 0 after a competition with a single bid. First 2024-02-06, latest 2026-04-24.

SECRETARIA DE ESTADO DA SAUDE2uncontested5awards40%of these awards

SECRETARIA DE ESTADO DA SAUDE gave BLANVER FARMOQUIMICA E FARMACEUTICA S.A 5 awards: 2 without a competition, 0 after a competition with a single bid. First 2024-12-13, latest 2026-06-10.

Latest awards without a rival

DateBuyerHowStated reason
2026-04-24FUNDACAO OSWALDO CRUZ
ocds-914jxj-25444607002892026
No competition
direct
tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modoDisputaId: 5; modoDisputaNome: Não se aplica; srp: false
2025-12-03SECRETARIA DE ESTADO DA SAUDE
ocds-914jxj-09110106003802025
No competition
direct
tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modoDisputaId: 5; modoDisputaNome: Não se aplica; srp: false
2025-03-13FUNDACAO OSWALDO CRUZ
ocds-914jxj-25444607010132025
No competition
direct
tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modoDisputaId: 5; modoDisputaNome: Não se aplica; srp: false
2024-12-27FUNDACAO OSWALDO CRUZ
ocds-914jxj-25444607014552024
No competition
direct
tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modoDisputaId: 5; modoDisputaNome: Não se aplica; srp: false
2024-12-13SECRETARIA DE ESTADO DA SAUDE
ocds-914jxj-09110106000932024
No competition
direct
tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modoDisputaId: 5; modoDisputaNome: Não se aplica; srp: false
2024-09-03FUNDACAO OSWALDO CRUZ
ocds-914jxj-25444607013702024
No competition
direct
tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modoDisputaId: 5; modoDisputaNome: Não se aplica; srp: false

Every uncontested award in Brazil · All countries · BLANVER FARMOQUIMICA E FARMACEUTICA S.A in the register

Source: contract awards published by the Ministry of Management and Innovation in Public Services of Brazil (Compras.gov.br, federal government) in the Open Contracting Data Standard (data.open-contracting.org), licensed under CC BY 4.0; awards from January 2016 to 30 September 2026, accessed 15 October 2026. Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.